FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031489128> ?p ?o ?g. }

• W2031489128 endingPage "252" @default.
• W2031489128 startingPage "242" @default.
• W2031489128 abstract "The increasing rate of hip fractures is giving rise to a number of socio-economic problems for the aging community. In addition to being unable to resume their previous living habits, many patients fail to achieve full functional recovery after the fractures. Total hip arthroplasty (THA) is a successful operation for the majority of patients with all forms of hip fractures, being performed increasingly often throughout the world. Revision rates for THA range up to 20% per year. Aseptic loosening is the reason for 75% of the revisions. An additional problem post-THA is the rate of heterotopic soft tissue calcification after THA, resulting in severely impaired function, pain, and a reduced range of hip movement.In an open study, 37 women who had undergone cementless THA after accidental hip fractures were treated twice daily with 200 IU of salmon calcitonin nasal spray for 12 months. Simultaneously the patients received one bag of 1,000 mg calcium plus 880 IU vitamin D daily throughout the treatment period of 1 year. A parallel group of 38 women with a similar clinical status in terms of hip fractures and cementless THA were treated with only one bag of 1,000 mg calcium plus 880 IU vitamin D daily through the treatment period.The results of this 12-month clinical trial show that 200 IU of salmon calcitonin nasal spray per day significantly improves the clinical outcome of postmenopausal elderly women following THA. Treatment with a salmon calcitonin nasal spray significantly reduces bone turnover, loss of bone density, and pain. The functional status of the patients was improved and the risk of falling reduced by rehabilitation during the observation period of 12 months. Additionally, calcitonin promoted the repair of hip fractures and was associated with a significantly lesser rate of refractures as well as periprosthetic ossifications.The increasing revision rate for THA during the first year and the patient's problem of resuming their previous living habits are the main foci of our study. Calcitonin nasal spray seems to cause few side effects. The additive treatment appears to improve the clinical outcome of THA in elderly postmenopausal women." @default.
• W2031489128 created "2016-06-24" @default.
• W2031489128 creator A5012157601 @default.
• W2031489128 creator A5025953607 @default.
• W2031489128 creator A5043255698 @default.
• W2031489128 creator A5044207960 @default.
• W2031489128 creator A5068593907 @default.
• W2031489128 creator A5089485566 @default.
• W2031489128 date "2005-01-01" @default.
• W2031489128 modified "2023-10-04" @default.
• W2031489128 title "Clinical Outcome of Salmon Calcitonin Nasal Spray Treatment in Postmenopausal Women after Total Hip Arthroplasty" @default.
• W2031489128 cites W1966269436 @default.
• W2031489128 cites W1975873563 @default.
• W2031489128 cites W1984488767 @default.
• W2031489128 cites W1987401403 @default.
• W2031489128 cites W1992436652 @default.
• W2031489128 cites W1992607386 @default.
• W2031489128 cites W1993728905 @default.
• W2031489128 cites W1995999743 @default.
• W2031489128 cites W2001313880 @default.
• W2031489128 cites W2019707854 @default.
• W2031489128 cites W2023471859 @default.
• W2031489128 cites W2024686709 @default.
• W2031489128 cites W2027417301 @default.
• W2031489128 cites W2027852937 @default.
• W2031489128 cites W2029403036 @default.
• W2031489128 cites W2033633524 @default.
• W2031489128 cites W2034427928 @default.
• W2031489128 cites W2034537524 @default.
• W2031489128 cites W2036407545 @default.
• W2031489128 cites W2042661881 @default.
• W2031489128 cites W2044884069 @default.
• W2031489128 cites W2046876976 @default.
• W2031489128 cites W2049961814 @default.
• W2031489128 cites W2053689432 @default.
• W2031489128 cites W2056904968 @default.
• W2031489128 cites W2059366980 @default.
• W2031489128 cites W2066627369 @default.
• W2031489128 cites W2073469131 @default.
• W2031489128 cites W2075484386 @default.
• W2031489128 cites W2085131376 @default.
• W2031489128 cites W2087839146 @default.
• W2031489128 cites W2104552549 @default.
• W2031489128 cites W2106975935 @default.
• W2031489128 cites W2111186856 @default.
• W2031489128 cites W2113208406 @default.
• W2031489128 cites W2151032564 @default.
• W2031489128 cites W2163895773 @default.
• W2031489128 cites W2167774359 @default.
• W2031489128 cites W2233055603 @default.
• W2031489128 cites W2314110838 @default.
• W2031489128 cites W4234371446 @default.
• W2031489128 cites W4248929716 @default.
• W2031489128 doi "https://doi.org/10.1159/000085121" @default.
• W2031489128 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15980653" @default.
• W2031489128 hasPublicationYear "2005" @default.
• W2031489128 type Work @default.
• W2031489128 sameAs 2031489128 @default.
• W2031489128 citedByCount "21" @default.
• W2031489128 countsByYear W20314891282012 @default.
• W2031489128 countsByYear W20314891282013 @default.
• W2031489128 countsByYear W20314891282014 @default.
• W2031489128 countsByYear W20314891282015 @default.
• W2031489128 countsByYear W20314891282016 @default.
• W2031489128 countsByYear W20314891282017 @default.
• W2031489128 countsByYear W20314891282018 @default.
• W2031489128 countsByYear W20314891282021 @default.
• W2031489128 crossrefType "journal-article" @default.
• W2031489128 hasAuthorship W2031489128A5012157601 @default.
• W2031489128 hasAuthorship W2031489128A5025953607 @default.
• W2031489128 hasAuthorship W2031489128A5043255698 @default.
• W2031489128 hasAuthorship W2031489128A5044207960 @default.
• W2031489128 hasAuthorship W2031489128A5068593907 @default.
• W2031489128 hasAuthorship W2031489128A5089485566 @default.
• W2031489128 hasConcept C126322002 @default.
• W2031489128 hasConcept C141071460 @default.
• W2031489128 hasConcept C203014093 @default.
• W2031489128 hasConcept C2779627488 @default.
• W2031489128 hasConcept C2780973058 @default.
• W2031489128 hasConcept C2909401005 @default.
• W2031489128 hasConcept C71924100 @default.
• W2031489128 hasConcept C85663871 @default.
• W2031489128 hasConceptScore W2031489128C126322002 @default.
• W2031489128 hasConceptScore W2031489128C141071460 @default.
• W2031489128 hasConceptScore W2031489128C203014093 @default.
• W2031489128 hasConceptScore W2031489128C2779627488 @default.
• W2031489128 hasConceptScore W2031489128C2780973058 @default.
• W2031489128 hasConceptScore W2031489128C2909401005 @default.
• W2031489128 hasConceptScore W2031489128C71924100 @default.
• W2031489128 hasConceptScore W2031489128C85663871 @default.
• W2031489128 hasIssue "4" @default.
• W2031489128 hasLocation W20314891281 @default.
• W2031489128 hasLocation W20314891282 @default.
• W2031489128 hasOpenAccess W2031489128 @default.
• W2031489128 hasPrimaryLocation W20314891281 @default.
• W2031489128 hasRelatedWork W1991022333 @default.
• W2031489128 hasRelatedWork W2328715900 @default.
• W2031489128 hasRelatedWork W2348086994 @default.

• next